Archive: 21/12/2015
Afatinib a better choice for EGFR-mutated lung cancer in first-line treatment
Patients with EGFR-activating mutations in advanced lung cancer seem to benefit more from afatinib than gefitinib as first-line treatment, researchers report at the first ESMO Asia 2015 Congress in Singapore.
Dec 21, 2015
Women experiencing delay in labour willing to forsake their own birth plans
A new study of women's experiences of delay in labour has revealed that many mums-to-be are prepared to abandon their antenatal plans for how they wanted their labours and births to be.
Dec 21, 2015
The battle against the lingering, harmful residue that smoking leaves behind
When cigarette smoke is blown into the environment, its chemical constituents don't just vanish into thin air. Residue from the smoke settles into, accumulates and is stored in the surrounding environment, such as upholstery, ...
Dec 21, 2015